BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,968,000 | -44.0% | 58,069,000 | -29.8% | 0.33% | -41.4% |
| Q4 2021 | $60,688,000 | -46.9% | 82,696,000 | 0.0% | 0.56% | -42.8% |
| Q3 2021 | $114,303,000 | -4.3% | 82,696,000 | +13.8% | 0.99% | +8.6% |
| Q2 2021 | $119,378,000 | +8.2% | 72,696,000 | +9.0% | 0.91% | -2.6% |
| Q1 2021 | $110,306,000 | – | 66,696,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
| Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
| Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
| TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
| Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |